Invention Grant
- Patent Title: T7 alpha viral vector system
-
Application No.: US15776855Application Date: 2016-11-18
-
Publication No.: US10801041B2Publication Date: 2020-10-13
- Inventor: Thomas E. Wagner
- Applicant: ORBIS HEALTH SOLUTIONS, LLC
- Applicant Address: US SC Greenville
- Assignee: Orbis Health Solutions, LLC
- Current Assignee: Orbis Health Solutions, LLC
- Current Assignee Address: US SC Greenville
- Agency: Foley & Lardner LLP
- International Application: PCT/US2016/062703 WO 20161118
- International Announcement: WO2017/087763 WO 20170526
- Main IPC: C12N15/86
- IPC: C12N15/86 ; A61P37/04 ; A61K39/12 ; A61K39/145 ; C07K14/005 ; C12N5/074 ; A61K39/00

Abstract:
The present invention relates generally to a gene expression system utilizing an alphavirus replicon and T7 promoter. The system is capable of expressing proteins in the cell cytoplasm without integrating the gene of interest into the genome of a host cell. The invention has a wide range of applications such as producing induced pluripotent cells and vaccines against pathogens and cancers.
Public/Granted literature
- US20180371494A1 T7 ALPHA VIRAL VECTOR SYSTEM Public/Granted day:2018-12-27
Information query
IPC分类: